Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic
New Plenity patient prescriptions increased 3.5-fold within the first three weeks of the national media campaign launch The company has projected $58 million in net revenue in this first full launch year 2022 BOSTON, March 17 (Bernama-BUSINESS WIRE) — Gelesis (NYSE: GLS), the maker of Plenity, announced preliminary results from its…

